KPIs & Operating Metrics(New)
Biologics And Drug Delivery Revenue By CategoryBiologics And Drug Delivery Revenue By Category AnnualBreakdown Of AssetsCapital Equipment And Software Revenue By CategoryCapital Equipment And Software Revenue By Category AnnualCost Of RevenueDeferred RevenueEmployee StatisticsFunctional Neurosurgery Navigation And Therapy Revenue By CategoryFunctional Neurosurgery Navigation And Therapy Revenue By Category AnnualGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment, Net BreakdownRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Service LineRevenue By Service Line %Revenue By Service Line AnnualRevenue By Service Line Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Gross Profit (2020 - 2025)

ClearPoint Neuro (CLPT) has disclosed Gross Profit for 13 consecutive years, with $6.4 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 34.48% to $6.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.7 million through Dec 2025, up 18.67% year-over-year, with the annual reading at $22.7 million for FY2025, 18.67% up from the prior year.
  • Gross Profit hit $6.4 million in Q4 2025 for ClearPoint Neuro, up from $5.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.4 million in Q4 2025 to a low of $2.3 million in Q2 2021.
  • Historically, Gross Profit has averaged $4.0 million across 5 years, with a median of $3.5 million in 2022.
  • Biggest five-year swings in Gross Profit: dropped 11.04% in 2023 and later soared 59.56% in 2024.
  • Year by year, Gross Profit stood at $3.2 million in 2021, then grew by 5.72% to $3.4 million in 2022, then rose by 19.22% to $4.0 million in 2023, then rose by 18.66% to $4.8 million in 2024, then surged by 34.48% to $6.4 million in 2025.
  • Business Quant data shows Gross Profit for CLPT at $6.4 million in Q4 2025, $5.6 million in Q3 2025, and $5.6 million in Q2 2025.